Pilot Study to Assess the Feasibility and Initial Efficacy of Therapist-as-consultant, Game-based CI Therapy

Sponsor
Ohio State University (Other)
Overall Status
Completed
CT.gov ID
NCT03005457
Collaborator
Nationwide Children (Other)
32
1
2
29
1.1

Study Details

Study Description

Brief Summary

Pilot study to assess the feasibility and initial efficacy of therapist-as-consultant, game-based CI therapy. Pre/post study design. Participant received a target of 30 hours game-based motor intervention, 100 hours constraint of the less affected upper extremity, and 5 hours therapist consultation (including completion of a behavioral contract at the first study visit). Duration of intervention was 10 consecutive weekdays, with pre-treatment and post-treatment testing performed within 1 week prior to and 1 week post-intervention by an independent tester.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Hemiparesis Therapy with VR
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
32 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Low-cost Virtual Reality Gaming Platform for Neurorehabilitation of Hemiparesis
Study Start Date :
Jul 1, 2012
Actual Primary Completion Date :
Dec 1, 2014
Actual Study Completion Date :
Dec 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Stroke

Behavioral: Hemiparesis Therapy with VR
An in-home therapist-as-consultant model of CI therapy in which motor practice with shaping and the Motor Activity Log with problem solving were delivered via a custom avatar-based video game called Recovery Rapids

Experimental: Hemiparesis other

Behavioral: Hemiparesis Therapy with VR
An in-home therapist-as-consultant model of CI therapy in which motor practice with shaping and the Motor Activity Log with problem solving were delivered via a custom avatar-based video game called Recovery Rapids

Outcome Measures

Primary Outcome Measures

  1. Change in Motor Activity Log [Week 0 and Week 3]

    Self-report measure of arm use for daily activities

  2. Change in Wolf Motor Function Test [Week 0 and Week 3]

    Objective measure of motor function in a laboratory setting

Secondary Outcome Measures

  1. Kinematic Data [Week 0 and Week 3]

    Kinematic data recorded during game play

  2. Brief Kinesthesia test [Week 0 and Week 3]

    Clinical Assessment of sensation

  3. Patient Health Questionnaire [Week 0 and Week 3]

    Measures Depression

  4. Strok Specific Quality of Life Scale [Week 0 and Week 3]

    Quality of life measurement

  5. Weschler Adult Intelligence Scale Symbol Seach [Week 0 and Week 3]

    Cognitive processing speed assessment

  6. Montreal Cognitive Assessment [Week 0 and Week 3]

    Baseline cognitive screen

  7. Survey [Week 0 and Week 3]

    Survey on satisfaction with the intervention

  8. Mitt Compliance [Week 0 and Week 3]

    Hours of use

  9. Total game-play time [Week 0 and Week 3]

  10. Gestures [Week 0 and Week 3]

    Number of gestures of each type registered in game

  11. Bilateral activity monitors [Week 0 and Week 3]

    Objective measure of arm use

  12. Action Research Arm Test (ARAT) [Week 0 and Week 3]

    Asses Changes in Limb Function

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Provide signed and dated informed consent form

  • Willing to comply with all study procedures and be available for the duration of the study

  • Male or female aged > 17

  • Preserved ability to comprehend English and participate in basic elements of the therapy

  • Community-dwelling

  • Experienced mild to moderate hemiparesis at least six months prior

  • Can independently operate the gaming system (those with severe cognitive impairments can usually achieve this)

  • Corrected vision of at least 20/70 as assessed by their ability to identify game objects on the monitor from 5 feet away

Exclusion Criteria:
  • concurrent participation in other experimental upper extremity trials

  • concurrent participation in other outpatient rehabilitation for their upper extremity

  • Botox within the last 3 months (confound)

  • near-normal motor function (9-hole Peg Test score above the 10th percentile of a normative sample)

  • minimal nonuse (Motor Activity Log at baseline >2.5, Accelerometry > 60%)

  • major medical issues that would interfere with study treatments or make intensive rehabilitation difficult to tolerate

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Ohio State University, 2154 Dodd Hall Columbus Ohio United States 43210

Sponsors and Collaborators

  • Ohio State University
  • Nationwide Children

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Lynne Gauthier , PhD, Assistant Prof. PM&R, Ohio State University
ClinicalTrials.gov Identifier:
NCT03005457
Other Study ID Numbers:
  • 60047824
First Posted:
Dec 29, 2016
Last Update Posted:
Dec 29, 2016
Last Verified:
Dec 1, 2016
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 29, 2016